Join the club for FREE to access the whole archive and other member benefits.

Hiromitsu (Hiro) Nakauchi

Professor of Genetics at Stanford University School of Medicine.

Hiro Nakauchi obtained a M.D. from Yokohama City University School of Medicine and a Ph.D. in immunology from University of Tokyo Graduate School of Medicine. He isolated CD8 genes during his post-doc period at the Laboratory of Prof. Leonard Herzenberg at Stanford University. After returning to Japan, he started working on hematopoietic stem cells in his laboratory at RIKEN. In 1994, he became Professor of Immunology at the University of Tsukuba where he demonstrated that a single hematopoietic stem cell could reconstitute the entire hematopoietic system, a definitive experimental proof for the “stemness”. Since April 2002, he has been a Professor of Stem Cell Therapy in the Institute of Medical Science at The University of Tokyo (IMSUT). In 2008, he was appointed Director of newly established Center for Stem Cell Biology and Regenerative Medicine at IMSUT. Just recently, he returned to Stanford University as a faculty to continue his stem cell research at the Institute of Stem Cell Biology and Regenerative Medicine. Goals of his work are to translate discoveries in basic research into practical medical applications.

Visit website: https://med.stanford.edu/nakauchilab.html

 hiromitsu-nakauchi-hiro-4ab1a15b

See also: Academia Stanford University School of Medicine - Medical school that improves health through discoveries and innovation in health care, education and research

Details last updated 20-May-2020

Hiromitsu (Hiro) Nakauchi News

New Type of Stem Cells Could Lead to New Treatments

New Type of Stem Cells Could Lead to New Treatments

Futurism - 11-Oct-2017

Researchers create Expanded Potential Stem Cells (EPSCs) in mice. ES and iPS aren’t capable of g...

Two New Teams Join Global Effort to Bioengineer a New Liver

Two New Teams Join Global Effort to Bioengineer a New Liver

New Organ - 04-Feb-2015

New Organ, a collective initiative for biomedical engineering and regenerative medicine, announce...